Search
forResearch 10 of 97
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Cemiplimab-Induced Alopecia Areata
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- A bibliometric study of the top 100 most cited articles on melanoma: insights into research trends and characteristics
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →